USMIRC NEWS

• Teclistamab in relapse refractory myeloma in real-world Comparative Meta-Analysis of Triplet vs. Quadruplet Induction Regimens in Newly Diagnosed, Treatment Naïve, Multiple Myeloma.

• USMIRC Medal Awards winners 2024

• USMIRC group Social Media posts

• AQUILA Trial: Daratumumab for High-Risk Smoldering Multiple Myeloma